{
  "ticker": "APX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02974211",
  "id": "02974211",
  "pages": 11,
  "price_sensitive": true,
  "date": "20250730",
  "time": "0832",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250730/pdf/06m95bkrlxbl3t.pdf",
  "summary": "### **Appen Limited (ASX: APX) \u2013 Q2 FY25 Quarterly Report & Appendix 4C \u2013 Material Information**  \n\n#### **Key Highlights**  \n- **Revenue**:  \n  - Q2 FY25: **$51.9M** (-6% pcp, +3% qoq).  \n  - H1 FY25 (ex-Google): **$102.1M** (+2% pcp).  \n- **China Business**:  \n  - **Q2 revenue $23.7M** (+77% pcp).  \n  - Annualized run-rate **>$100M** in June.  \n  - **5th consecutive quarter of EBITDA profitability**.  \n- **US Market Challenges**:  \n  - Volatility in AI segment; delays in LLM projects.  \n  - US Government revenue opportunities under review.  \n- **Cost Efficiencies**: **~$10M annualized savings** identified (~70% executed by Q3 FY25).  \n- **Cash Balance**: **$60.9M** (down from $67.9M in Q1), with **17 quarters of funding coverage**.  \n- **FY25 Guidance**: Revenue tracking to **low end of $235M\u2013$260M range**.  \n\n#### **Appendix 4C (Cash Flow)**  \n- **Operating Cash Flow (Q2)**: **($3.5M)** (vs. $16.6M inflow in Q1).  \n- **Investing Cash Flow**: **($4.2M)** (IP/product development spend).  \n\n#### **Valuation Impact**  \n1. **China strength offset by US weakness** \u2013 structural divergence in performance.  \n2. **Guidance downgrade** (low end of range) due to US uncertainty.  \n\nOmitted: Director commentary, non-material operational details.",
  "usage": {
    "prompt_tokens": 5437,
    "completion_tokens": 379,
    "total_tokens": 5816,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-29T22:50:33.146865"
}